Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1981-1-16
pubmed:abstractText
1 The effect of imipramine in concentrations between 0.01 microM and 50 microM has been studied on bovine Purkinje fibres and ventricular muscle transmembrane potentials. 2 In electrically stimulated fibres, imipramine had no effect on the resting membrane potential, but decreased the action potential amplitude, overshoot and maximum rate of depolarization (Vmax). 3 In Purkinje fibres, imipramine also decreased the conduction velocity and shifted the membrane responsiveness and recovery time curves downward and to the right. 4 In both Purkinje fibres and ventricular muscle, imipramine decreased the amplitude of phase 2 and prolonged phase 3. In Purkinje fibres, imipramine did not alter the action potential duration (APD) but prolonged the effective refractory period (ERP). In ventricular muscle, at concentrations higher than 1 microM imipramine shortened both the APD and the ERP and made the ERP long as compared to APD. 5 Imipramine decreased the slope of phase 4 diastolic depolarization in spontaneously beating Purkinje fibres. 6 These properties of imipramine are quite similar to those of quinidine or procainamide (class 1 antiarrhythmics). The mechanisms responsible for the cardiac effect of imipramine are discussed.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/7426828-1057916, http://linkedlifedata.com/resource/pubmed/commentcorrection/7426828-1094483, http://linkedlifedata.com/resource/pubmed/commentcorrection/7426828-1142111, http://linkedlifedata.com/resource/pubmed/commentcorrection/7426828-13264118, http://linkedlifedata.com/resource/pubmed/commentcorrection/7426828-13476371, http://linkedlifedata.com/resource/pubmed/commentcorrection/7426828-13584729, http://linkedlifedata.com/resource/pubmed/commentcorrection/7426828-13754380, http://linkedlifedata.com/resource/pubmed/commentcorrection/7426828-14060478, http://linkedlifedata.com/resource/pubmed/commentcorrection/7426828-14126352, http://linkedlifedata.com/resource/pubmed/commentcorrection/7426828-14354640, http://linkedlifedata.com/resource/pubmed/commentcorrection/7426828-16992119, http://linkedlifedata.com/resource/pubmed/commentcorrection/7426828-4253824, http://linkedlifedata.com/resource/pubmed/commentcorrection/7426828-4264878, http://linkedlifedata.com/resource/pubmed/commentcorrection/7426828-4413144, http://linkedlifedata.com/resource/pubmed/commentcorrection/7426828-456414, http://linkedlifedata.com/resource/pubmed/commentcorrection/7426828-4568668, http://linkedlifedata.com/resource/pubmed/commentcorrection/7426828-4573419, http://linkedlifedata.com/resource/pubmed/commentcorrection/7426828-4687226, http://linkedlifedata.com/resource/pubmed/commentcorrection/7426828-5544795, http://linkedlifedata.com/resource/pubmed/commentcorrection/7426828-667453
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0007-1188
pubmed:author
pubmed:issnType
Print
pubmed:volume
70
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
15-23
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1980
pubmed:articleTitle
Electrophysiological effects of imipramine on bovine ventricular muscle and Purkinje fibres.
pubmed:publicationType
Journal Article, In Vitro